Cargando…

Comparison of nodal staging between CT, MRI, and [(18)F]-FDG PET/MRI in patients with newly diagnosed breast cancer

PURPOSE: To compare CT, MRI, and [(18)F]-fluorodeoxyglucose positron emission tomography ([(18)F]-FDG PET/MRI) for nodal status, regarding quantity and location of metastatic locoregional lymph nodes in patients with newly diagnosed breast cancer. MATERIALS AND METHODS: One hundred eighty-two patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morawitz, Janna, Bruckmann, Nils-Martin, Dietzel, Frederic, Ullrich, Tim, Bittner, Ann-Kathrin, Hoffmann, Oliver, Ruckhäberle, Eugen, Mohrmann, Svjetlana, Häberle, Lena, Ingenwerth, Marc, Abrar, Daniel Benjamin, Sawicki, Lino Morris, Breuckmann, Katharina, Fendler, Wolfgang Peter, Herrmann, Ken, Buchbender, Christian, Antoch, Gerald, Umutlu, Lale, Kirchner, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803812/ https://www.ncbi.nlm.nih.gov/pubmed/34476552 http://dx.doi.org/10.1007/s00259-021-05502-0

Ejemplares similares

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Prospective comparison of CT and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Prospective evaluation of whole-body MRI and (18)F-FDG PET/MRI in N and M staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2020)

Conventional Imaging, MRI and (18)F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
por: Morawitz, Janna, et al.
Publicado: (2023)

Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in (18)F-FDG PET/MRI
por: Bruckmann, Nils Martin, et al.
Publicado: (2022)

Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times
por: Jannusch, Kai, et al.
Publicado: (2023)

Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI—Clinically Relevant?
por: Jannusch, Kai, et al.
Publicado: (2022)

Multiparametric (18)F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Umutlu, Lale, et al.
Publicado: (2022)

Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography
por: Dietzel, Frederic, et al.
Publicado: (2023)

[(18)F]FDG PET/MRI in children suffering from lymphoma: does MRI contrast media make a difference?
por: Jannusch, Kai, et al.
Publicado: (2023)

Multiparametric Integrated (18)F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
por: Umutlu, Lale, et al.
Publicado: (2021)

Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
por: Jannusch, Kai, et al.
Publicado: (2023)

Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast (18)F-FDG PET/MRI compared to (18)F-FDG PET/CT and CT
por: Kirchner, Julian, et al.
Publicado: (2017)

Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body (68) Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?
por: Morawitz, Janna, et al.
Publicado: (2022)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021)

(18)F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis
por: Deuschl, Cornelius, et al.
Publicado: (2020)

Update on Locoregional Therapies for Cholangiocellular Carcinoma
por: Morawitz, Janna, et al.
Publicado: (2023)

A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
por: Demircioglu, Aydin, et al.
Publicado: (2020)

Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI
por: Grueneisen, Johannes, et al.
Publicado: (2016)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI
por: Schaarschmidt, Benedikt Michael, et al.
Publicado: (2015)

Impact of Different Metal Artifact Reduction Techniques on Attenuation Correction of Normal Organs in (18)F-FDG-PET/CT
por: Morawitz, Janna, et al.
Publicado: (2022)

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
por: Boschheidgen, M., et al.
Publicado: (2022)

Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma: Preliminary Results
por: Chodyla, Michal, et al.
Publicado: (2022)

CT/MRI of nodal metastases in pelvic cancer
por: Husband, Janet E.
Publicado: (2015)

(18) F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine
por: Kirchner, Julian, et al.
Publicado: (2017)

Reply to Letter to the Editor: “The added benefit of contrast-enhanced CT in the evaluation of incidental FDG-avid colon lesions”
por: Kirchner, Julian, et al.
Publicado: (2020)

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
por: Klingebiel, M, et al.
Publicado: (2022)

Accuracy of [(18)F]FDG PET/MRI for the Detection of Liver Metastases
por: Beiderwellen, Karsten, et al.
Publicado: (2015)

7 T renal MRI: challenges and promises
por: de Boer, Anneloes, et al.
Publicado: (2016)

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Diffuse Axonal Injury at Ultra-High Field MRI
por: Moenninghoff, Christoph, et al.
Publicado: (2015)

Cardiac PET/MRI—an update
por: Rischpler, C., et al.
Publicado: (2019)

Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue Sarcomas
por: Chodyla, Michal, et al.
Publicado: (2021)

MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison
por: Zhang, Zhiwen, et al.
Publicado: (2023)

The potential of predictive and prognostic breast MRI (P2-bMRI)
por: Dietzel, Matthias, et al.
Publicado: (2022)

Optimization of Acquisition time of (68)Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer
por: Lütje, Susanne, et al.
Publicado: (2016)

1.5 versus 3 versus 7 Tesla in abdominal MRI: A comparative study
por: Laader, Anja, et al.
Publicado: (2017)

Correlation of Standardized Uptake Value and Apparent Diffusion Coefficient in Integrated Whole-Body PET/MRI of Primary and Recurrent Cervical Cancer
por: Grueneisen, Johannes, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0oslunr09nbo4dq1ftbaabe08b